| Name: | Atazanavir Impurity 1 |
| Catalogue No. | VL2230005 |
| CAS No. | 1292296-09-3 |
| Molecular Formula | C38H52N6O7 |
| Molecular Weight | 704.87 |
| Status | In-stock |
| IUPAC Name | methyl ((5S,8S,9R,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate |
| Description | Atazanavir Impurity 1(CAS No: 1292296-09-3) or methyl ((5S,8S,9R,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate is an impurity of atazanavir. it is an azapeptide and it acts as selective inhibition of viral Gag and Gag–Pol polyprotein processing in HIV-1-infected cells.it also used to decrease the risk of spreading HIV disease to others. it is used with other HIV medications for infants and childre |
| References | Achenbach, Chad J., et al. “Atazanavir/Ritonavir-Based Combination Antiretroviral Therapy for Treatment of HIV-1 Infection in Adults.” Future Virology, vol. 6, no. 2, Feb. 2011, pp. 157–77, https://doi.org/10.2217/fvl.10.89. |
